Last week, sunny San Diego was the site of a big event (no, I don’t mean, Comic Con): the 2014 DNA Vaccine Conference hosted by the International Society of DNA Vaccines (ISDV). I thought I’d take the opportunity to describe some of the “best of conference,” as seen through the completely biased eyes of OncoSec’s CMO and what it means for our mission of furthering intratumoral immunotherapy.
This week, our CEO, Punit Dhillon, presented at the 15th Annual Rodman & Renshaw Global Investment Conference. The annual event hosted over 150 established and emerging biotech and pharmaceutical companies. During the presentation, Mr. Dhillon reviewed previous data points and provided an update on upcoming milestones. Here is an overview of the presentation: